GC Biopharma Corp. (006280.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

36.7x

EV/EBITDA

17.3x

Market Cap

KRW 1.46T

MomentumView details →

1D Return

+0.00%

YTD Return

−19.75%

RSI (14)

52.0

ValuationView details →

P/E (Fwd)

36.7x

EV/EBITDA

17.3x

Market Cap

KRW 1.46T

RSI (14)

52.0

MomentumView details →

1D Return

+0.00%

YTD Return

−19.75%

ProfitabilityView details →

Gross Margin

25.04%

Net Margin

−2.54%

EBITDA Margin

7.19%

ROE (TTM)

−4.04%

ROA (TTM)

−1.77%

Asset Turnover

0.70x

GrowthView details →

Revenue YoY

+9.73%

EPS YoY

—

FCF YoY

+183.12%

Revenue CAGR 3Y

+5.18%

EPS CAGR 3Y

+82.22%

EBITDA YoY

+21.05%

EarningsView details →

EPS (Actual)

KRW 901.87

EPS Surprise

−7.39%

Beats (12Q)

0/12

Next Q EPS Est

KRW 2,003.02

Avg Surprise (4Q)

−3.69%

Rev Surprise

−8.17%

Capital & dividendView details →

Debt/Equity

0.76x

Current Ratio

1.35x

Quick Ratio

0.47x

Div Yield

1.18%

Div Rate

KRW 1,500.00

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

1.96T

Net Income (TTM)

−49.90B

Op. CF (TTM)

184.28B

Next earningsNov 3, 2026 →

Latest newsMore news →

No recent news for 006280.KS.

Similar companies

Mezzion Pharma Co.,Ltd.140410.KQ ST Pharm Co.,Ltd.237690.KQ Sam Chun Dang Pharm. Co., Ltd000250.KQ Komipharm International Co., Ltd.041960.KQ Hyundai Bioscience Co., Ltd.048410.KQ ABL Bio Inc.298380.KQ Find similar companies →

Latest newsMore news →

No recent news for 006280.KS.